pubmed.ncbi.nlm.nih.gov

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function - PubMed

  • ️Wed Jan 01 1997

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

V Large et al. J Clin Invest. 1997.

Abstract

Catecholamines play a central role in the regulation of energy expenditure, in part by stimulating lipid mobilization through lipolysis in fat cells. The beta-2 adrenoceptor (BAR-2) is a major lipolytic receptor in human fat cells. To determine whether known polymorphisms in codons 16, 27, and 164 of this receptor play a role in obesity and subcutaneous adipocyte BAR-2 lipolytic function, we investigated a group of 140 women with a large variation in body fat mass. Only the polymorphisms in codons 16 and 27 were common in the study population. The Gln27Glu polymorphism was markedly associated with obesity with a relative risk for obesity of approximately 7 and an odds ratio of approximately 10. Homozygotes for Glu27 had an average fat mass excess of 20 kg and approximately 50% larger fat cells than controls. However, no significant association with changes in BAR-2 function was observed. The Arg16Gly polymorphism was associated with altered BAR-2 function with Gly16 carriers showing a fivefold increased agonist sensitivity and without any change in BAR-2 expression. However, it was not significantly linked with obesity. These findings suggest that genetic variability in the human BAR-2 gene could be of major importance for obesity, energy expenditure, and lipolytic BAR-2 function in adipose tissue, at least in women.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1995 Aug 10;333(6):348-51 - PubMed
    1. N Engl J Med. 1995 Aug 10;333(6):343-7 - PubMed
    1. Pulm Pharmacol. 1995 Feb;8(1):1-10 - PubMed
    1. Am J Epidemiol. 1996 Feb 1;143(3):228-39 - PubMed
    1. Clin Exp Allergy. 1995 Nov;25 Suppl 2:89-94; discussion 95-6 - PubMed

Publication types

MeSH terms

Substances